AstraZeneca races to adapt Covid vaccine as South Africa suspends rollout

Drugmaker AstraZeneca is racing to adapt its Covid-19 vaccine in the face of new variants of the virus.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.